AIG
RUBY

American International Group’s Rubius Therapeutics, Inc RUBY Stock Holding History

American International Group’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,802
Closed -$126K – 3360
2022
Q1 		$126K Sell
22,802
-1,606
-7% -$10.2K ﹤0.01% 2498
2021
Q4 		$236K Sell
24,408
-730
-3% -$10.1K ﹤0.01% 2270
2021
Q3 		$449K Sell
25,138
-125
-0.5% -$2.72K ﹤0.01% 1922
2021
Q2 		$617 Buy
25,263
+4,374
+21% +$109K ﹤0.01% 1791
2021
Q1 		$554 Buy
20,889
+55
+0.3% +$803 ﹤0.01% 1773
2020
Q4 		$158 Sell
20,834
-599
-3% -$3.56K ﹤0.01% 2405
2020
Q3 		$107K Sell
21,433
-486
-2% -$2.57K ﹤0.01% 2498
2020
Q2 		$131K Buy
21,919
+1,235
+6% +$7.29K ﹤0.01% 2360
2020
Q1 		$92K Sell
20,684
-1,196
-5% -$8.88K ﹤0.01% 2358
2019
Q4 		$208K Sell
21,880
-185
-0.8% -$1.79K ﹤0.01% 2201
2019
Q3 		$173K Sell
22,065
-153
-0.7% -$1.78K ﹤0.01% 2272
2019
Q2 		$349K Buy
22,218
+482
+2% +$7.78K ﹤0.01% 1906
2019
Q1 		$393K Buy
21,736
+13,725
+171% +$211K ﹤0.01% 1849
2018
Q4 		$129K Sell
8,011
-61
-0.8% -$1.11K ﹤0.01% 2451
2018
Q3 		$194K Buy
+8,072
New +$185K ﹤0.01% 2440

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American International Group's RUBY Position: Q2 2022 in Review

American International Group sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 22,802 shares — an estimated $126K sold.

American International Group first reported a position in RUBY in Q3 2018 and held it in 15 quarters. The position peaked at $449K in Q3 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • American International Group reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 22,802 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $126K.
  • American International Group first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 15 quarters.
  • American International Group's Rubius Therapeutics, Inc position peaked at $449K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.